Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhengye Biotechnology Holding FCF Yield %?
Zhengye Biotechnology HoldingZYBT -1.03%20 FCF Yield % is 0.15 as of Aug. 25, 2026, which is 65% below its 10-year median of 0.43. GuruFocus rates ZYBT with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 1,003 Drug Manufacturers companies, Zhengye Biotechnology Holding ranks worse than 53.24% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Zhengye Biotechnology Holding FCF Yield % Related Terms
Zhengye Biotechnology Holding FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhengye Biotechnology Holding's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhengye Biotechnology Holding FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhengye Biotechnology Holding's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Zhengye Biotechnology Holding's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhengye Biotechnology Holding (ZYBT) has a FCF Yield % of 0.15 as of Aug. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Zhengye Biotechnology Holding and its competitors. This is 65% below median its historical median of 0.43. Over the past decade, Zhengye Biotechnology Holding's FCF Yield % has ranged from 0.10 to 2.53. According to the industry distribution chart, Zhengye Biotechnology Holding ranks #534 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 53.2%.
Is Zhengye Biotechnology Holding's FCF Yield % too high?
Zhengye Biotechnology Holding's current FCF Yield % of 0.15 is 65% below median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 2.53. The Drug Manufacturers industry median FCF Yield % is 0.64. Zhengye Biotechnology Holding's value of 0.15 is 76.6% below this industry median. Based on the distribution chart, Zhengye Biotechnology Holding ranks #534 out of 1003 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zhengye Biotechnology Holding has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Zhengye Biotechnology Holding's FCF Yield % compare to TLPH and CPHI?
According to the Drug Manufacturers industry distribution chart, Zhengye Biotechnology Holding ranks #534 out of 1003 companies for FCF Yield %. This places Zhengye Biotechnology Holding in the lower half of its industry. The industry median FCF Yield % is 0.64. Zhengye Biotechnology Holding's value of 0.15 is 76.6% below this benchmark. Historically, Zhengye Biotechnology Holding's own FCF Yield % has ranged from 0.10 to 2.53 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 0.64, Zhengye Biotechnology Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.64, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhengye Biotechnology Holding's current FCF Yield % of 0.15 is 76.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Zhengye Biotechnology Holding and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhengye Biotechnology Holding's current FCF Yield % is 0.15, which is 65% below median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhengye Biotechnology Holding stock overvalued right now?
Zhengye Biotechnology Holding (ZYBT) has a current FCF Yield % of 0.15. The current FCF Yield % is 0.15, which is 65% below median its 10-year median of 0.43 and 76.6% below the Drug Manufacturers industry median of 0.64. Zhengye Biotechnology Holding's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Zhengye Biotechnology Holding (ZYBT), the current FCF Yield % is 0.15 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
20GF Score
Get the complete analysis for ZYBT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZYBT has been successfully added to your 
